Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade

Joseph L. Benci, Lexus R. Johnson, Ruth Choa, Yuanming Xu, Jingya Qiu, Zilu Zhou, B. Xu, Darwin Ye, Katherine L. Nathanson, Carl H. June, E. John Wherry, Nancy R. Zhang, Hemant Ishwaran, Matthew D. Hellmann, Jedd D. Wolchok, Taku Kambayashi, Andy J. Minn

Research output: Contribution to journalArticle

Abstract

Interferon-gamma (IFNG) augments immune function yet promotes T cell exhaustion through PDL1. How these opposing effects are integrated to impact immune checkpoint blockade (ICB) is unclear. We show that while inhibiting tumor IFNG signaling decreases interferon-stimulated genes (ISGs) in cancer cells, it increases ISGs in immune cells by enhancing IFNG produced by exhausted T cells (TEX). In tumors with favorable antigenicity, these TEX mediate rejection. In tumors with neoantigen or MHC-I loss, TEX instead utilize IFNG to drive maturation of innate immune cells, including a PD1+TRAIL+ ILC1 population. By disabling an inhibitory circuit impacting PD1 and TRAIL, blocking tumor IFNG signaling promotes innate immune killing. Thus, interferon signaling in cancer cells and immune cells oppose each other to establish a regulatory relationship that limits both adaptive and innate immune killing. In melanoma and lung cancer patients, perturbation of this relationship is associated with ICB response independent of tumor mutational burden. The opposing effects of interferon-gamma in terms of regulating immune function but also driving T cell exhaustion through PDL1 is explained by its differential effects in tumor and immune cell populations.

Original languageEnglish (US)
Pages (from-to)933-948.e14
JournalCell
Volume178
Issue number4
DOIs
StatePublished - Aug 8 2019

Fingerprint

Adaptive Immunity
Innate Immunity
Interferons
Interferon-gamma
Tumors
T-cells
Neoplasms
Cells
T-Lymphocytes
Genes
Neoplasm Genes
Tumor Burden
Population
Melanoma
Lung Neoplasms
Networks (circuits)

Keywords

  • CTLA4
  • immune checkpoint blockade
  • immunotherapy resistance
  • innate lymphoid cells
  • interferon
  • ISGs
  • NK cells
  • PDL1
  • T cell exhaustion

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Benci, J. L., Johnson, L. R., Choa, R., Xu, Y., Qiu, J., Zhou, Z., ... Minn, A. J. (2019). Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade. Cell, 178(4), 933-948.e14. https://doi.org/10.1016/j.cell.2019.07.019

Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade. / Benci, Joseph L.; Johnson, Lexus R.; Choa, Ruth; Xu, Yuanming; Qiu, Jingya; Zhou, Zilu; Xu, B.; Ye, Darwin; Nathanson, Katherine L.; June, Carl H.; Wherry, E. John; Zhang, Nancy R.; Ishwaran, Hemant; Hellmann, Matthew D.; Wolchok, Jedd D.; Kambayashi, Taku; Minn, Andy J.

In: Cell, Vol. 178, No. 4, 08.08.2019, p. 933-948.e14.

Research output: Contribution to journalArticle

Benci, JL, Johnson, LR, Choa, R, Xu, Y, Qiu, J, Zhou, Z, Xu, B, Ye, D, Nathanson, KL, June, CH, Wherry, EJ, Zhang, NR, Ishwaran, H, Hellmann, MD, Wolchok, JD, Kambayashi, T & Minn, AJ 2019, 'Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade', Cell, vol. 178, no. 4, pp. 933-948.e14. https://doi.org/10.1016/j.cell.2019.07.019
Benci, Joseph L. ; Johnson, Lexus R. ; Choa, Ruth ; Xu, Yuanming ; Qiu, Jingya ; Zhou, Zilu ; Xu, B. ; Ye, Darwin ; Nathanson, Katherine L. ; June, Carl H. ; Wherry, E. John ; Zhang, Nancy R. ; Ishwaran, Hemant ; Hellmann, Matthew D. ; Wolchok, Jedd D. ; Kambayashi, Taku ; Minn, Andy J. / Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade. In: Cell. 2019 ; Vol. 178, No. 4. pp. 933-948.e14.
@article{d6397d3143524368baab574d29372b4c,
title = "Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade",
abstract = "Interferon-gamma (IFNG) augments immune function yet promotes T cell exhaustion through PDL1. How these opposing effects are integrated to impact immune checkpoint blockade (ICB) is unclear. We show that while inhibiting tumor IFNG signaling decreases interferon-stimulated genes (ISGs) in cancer cells, it increases ISGs in immune cells by enhancing IFNG produced by exhausted T cells (TEX). In tumors with favorable antigenicity, these TEX mediate rejection. In tumors with neoantigen or MHC-I loss, TEX instead utilize IFNG to drive maturation of innate immune cells, including a PD1+TRAIL+ ILC1 population. By disabling an inhibitory circuit impacting PD1 and TRAIL, blocking tumor IFNG signaling promotes innate immune killing. Thus, interferon signaling in cancer cells and immune cells oppose each other to establish a regulatory relationship that limits both adaptive and innate immune killing. In melanoma and lung cancer patients, perturbation of this relationship is associated with ICB response independent of tumor mutational burden. The opposing effects of interferon-gamma in terms of regulating immune function but also driving T cell exhaustion through PDL1 is explained by its differential effects in tumor and immune cell populations.",
keywords = "CTLA4, immune checkpoint blockade, immunotherapy resistance, innate lymphoid cells, interferon, ISGs, NK cells, PDL1, T cell exhaustion",
author = "Benci, {Joseph L.} and Johnson, {Lexus R.} and Ruth Choa and Yuanming Xu and Jingya Qiu and Zilu Zhou and B. Xu and Darwin Ye and Nathanson, {Katherine L.} and June, {Carl H.} and Wherry, {E. John} and Zhang, {Nancy R.} and Hemant Ishwaran and Hellmann, {Matthew D.} and Wolchok, {Jedd D.} and Taku Kambayashi and Minn, {Andy J.}",
year = "2019",
month = "8",
day = "8",
doi = "10.1016/j.cell.2019.07.019",
language = "English (US)",
volume = "178",
pages = "933--948.e14",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade

AU - Benci, Joseph L.

AU - Johnson, Lexus R.

AU - Choa, Ruth

AU - Xu, Yuanming

AU - Qiu, Jingya

AU - Zhou, Zilu

AU - Xu, B.

AU - Ye, Darwin

AU - Nathanson, Katherine L.

AU - June, Carl H.

AU - Wherry, E. John

AU - Zhang, Nancy R.

AU - Ishwaran, Hemant

AU - Hellmann, Matthew D.

AU - Wolchok, Jedd D.

AU - Kambayashi, Taku

AU - Minn, Andy J.

PY - 2019/8/8

Y1 - 2019/8/8

N2 - Interferon-gamma (IFNG) augments immune function yet promotes T cell exhaustion through PDL1. How these opposing effects are integrated to impact immune checkpoint blockade (ICB) is unclear. We show that while inhibiting tumor IFNG signaling decreases interferon-stimulated genes (ISGs) in cancer cells, it increases ISGs in immune cells by enhancing IFNG produced by exhausted T cells (TEX). In tumors with favorable antigenicity, these TEX mediate rejection. In tumors with neoantigen or MHC-I loss, TEX instead utilize IFNG to drive maturation of innate immune cells, including a PD1+TRAIL+ ILC1 population. By disabling an inhibitory circuit impacting PD1 and TRAIL, blocking tumor IFNG signaling promotes innate immune killing. Thus, interferon signaling in cancer cells and immune cells oppose each other to establish a regulatory relationship that limits both adaptive and innate immune killing. In melanoma and lung cancer patients, perturbation of this relationship is associated with ICB response independent of tumor mutational burden. The opposing effects of interferon-gamma in terms of regulating immune function but also driving T cell exhaustion through PDL1 is explained by its differential effects in tumor and immune cell populations.

AB - Interferon-gamma (IFNG) augments immune function yet promotes T cell exhaustion through PDL1. How these opposing effects are integrated to impact immune checkpoint blockade (ICB) is unclear. We show that while inhibiting tumor IFNG signaling decreases interferon-stimulated genes (ISGs) in cancer cells, it increases ISGs in immune cells by enhancing IFNG produced by exhausted T cells (TEX). In tumors with favorable antigenicity, these TEX mediate rejection. In tumors with neoantigen or MHC-I loss, TEX instead utilize IFNG to drive maturation of innate immune cells, including a PD1+TRAIL+ ILC1 population. By disabling an inhibitory circuit impacting PD1 and TRAIL, blocking tumor IFNG signaling promotes innate immune killing. Thus, interferon signaling in cancer cells and immune cells oppose each other to establish a regulatory relationship that limits both adaptive and innate immune killing. In melanoma and lung cancer patients, perturbation of this relationship is associated with ICB response independent of tumor mutational burden. The opposing effects of interferon-gamma in terms of regulating immune function but also driving T cell exhaustion through PDL1 is explained by its differential effects in tumor and immune cell populations.

KW - CTLA4

KW - immune checkpoint blockade

KW - immunotherapy resistance

KW - innate lymphoid cells

KW - interferon

KW - ISGs

KW - NK cells

KW - PDL1

KW - T cell exhaustion

UR - http://www.scopus.com/inward/record.url?scp=85069924248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069924248&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2019.07.019

DO - 10.1016/j.cell.2019.07.019

M3 - Article

VL - 178

SP - 933-948.e14

JO - Cell

JF - Cell

SN - 0092-8674

IS - 4

ER -